Outsourced microbiological support to hospital-based surveillance of CDI aims to increase the capacity of laboratories in EU/EEA Member States to perform diagnostic practices with high diagnostic accuracy and acquire comparable typing data from C. difficile isolates.
This report provides an overview of the cases of hepatitis of unknown origin in children aged 16 years and below reported to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy).
The fifth meeting of the Hepatitis B and C Network aims to bring together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
For EAAD 2018 ECDC will host the event “One Health to Keep Antibiotics Working” where ECDC will present the latest estimates of the health burden of antibiotic resistance, and the new data on the prevalence of healthcare-associated infections and of antimicrobial consumption in acute care hospitals and long-term care facilities in the EU/EEA.
The key objective of this meeting was to verify the rationale and objectives of molecular typing for surveillance of hepatitis E virus (HEV) through the hepatitis E network (HEVnet). The workshop reviewed HEVnet as a tool for molecular surveillance of HEV in Europe.
The 31st IUSTI (International Union Against Sexually Transmitted Infections) Europe Congress addressed the broad range of science and clinical practice in the field of sexually transmitted infections.
Infographics on acute care hospitals, healthcare-associated infections, antimicrobial use, antimicrobial resistance, based on the ECDC Point prevalence survey